Group One Trading’s GSK GSK Stock Holding History

Group One Trading’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.71M	Buy	67,200 +6,700	+11%	+$363K	0.01%	1542
2025 Q4	$2.97M	Buy	60,500 +36,400	+151%	+$1.7M	0.01%	1927
2025 Q3	$1.04M	Sell	24,100 -154,400	-86%	-$6.03M	﹤0.01%	2995
2025 Q2	$6.85M	Sell	178,500 -290,300	-62%	-$11.1M	0.02%	1084
2025 Q1	$18.2M	Buy	468,800 +435,500	+1,308%	+$15.9M	0.05%	354
2024 Q4	$1.13M	Buy	33,300 +24,700	+287%	+$889K	﹤0.01%	2471
2024 Q3	$352K	Buy	8,600 +1,200	+16%	+$49.1K	﹤0.01%	3122
2024 Q2	$285K	Sell	7,400 -2,000	-21%	-$84.1K	﹤0.01%	3090
2024 Q1	$403K	Sell	9,400 -14,800	-61%	-$610K	﹤0.01%	2944
2023 Q4	$897K	Buy	24,200 +300	+1%	+$10.8K	﹤0.01%	2552
2023 Q3	$866K	Buy	23,900 +300	+1%	+$10.6K	﹤0.01%	2414
2023 Q2	$841K	Sell	23,600 -9,700	-29%	-$348K	﹤0.01%	2517
2023 Q1	$1.18M	Sell	33,300 -180,400	-84%	-$6.31M	﹤0.01%	1986
2022 Q4	$7.51M	Buy	213,700 +30,900	+17%	+$1.03M	0.02%	901
2022 Q3	$5.38M	Buy	182,800 +79,520	+77%	+$3.01M	0.01%	1115
2022 Q2	$5.62M	Sell	103,280 -21,200	-17%	-$1.17M	0.01%	1212
2022 Q1	$6.78M	Sell	124,480 -92,400	-43%	-$5.02M	0.01%	1296
2021 Q4	$12M	Buy	216,880 +34,080	+19%	+$1.77M	0.01%	986
2021 Q3	$8.73M	Buy	182,800 +10,000	+6%	+$502K	0.01%	1178
2021 Q2	$8.6M	Buy	172,800 +31,920	+23%	+$1.53M	0.01%	1193
2021 Q1	$6.29M	Sell	140,880 -3,440	-2%	-$156K	0.01%	1322
2020 Q4	$6.64M	Buy	144,320 +52,400	+57%	+$2.41M	0.01%	1086
2020 Q3	$4.33M	Buy	91,920 +56,960	+163%	+$2.85M	0.01%	1015
2020 Q2	$1.78M	Sell	34,960 -8,000	-19%	-$410K	0.01%	1550
2020 Q1	$2.04M	Buy	42,960 +20,720	+93%	+$1.11M	0.02%	1035
2019 Q4	$1.31M	Buy	22,240 +14,720	+196%	+$819K	0.01%	1653
2019 Q3	$401K	Buy	7,520 +3,680	+96%	+$189K	﹤0.01%	2519
2019 Q2	$192K	Sell	3,840 -20,160	-84%	-$1.01M	﹤0.01%	2881
2019 Q1	$1.25M	Sell	24,000 -26,400	-52%	-$1.32M	0.01%	1254
2018 Q4	$2.41M	Sell	50,400 -45,840	-48%	-$2.26M	0.02%	912
2018 Q3	$4.83M	Buy	96,240 +38,560	+67%	+$1.96M	0.04%	603
2018 Q2	$2.91M	Sell	57,680 -101,040	-64%	-$5.09M	0.02%	860
2018 Q1	$7.75M	Buy	158,720 +137,760	+657%	+$6.42M	0.08%	304
2017 Q4	$929K	Sell	20,960 -7,440	-26%	-$344K	0.01%	1766
2017 Q3	$1.44M	Sell	28,400 -9,120	-24%	-$463K	0.01%	1300
2017 Q2	$2.02M	Sell	37,520 -28,720	-43%	-$1.53M	0.02%	946
2017 Q1	$3.49M	Sell	66,240 -10,320	-13%	-$524K	0.04%	558
2016 Q4	$3.69M	Buy	76,560 +39,280	+105%	+$1.94M	0.04%	562
2016 Q3	$2.01M	Sell	37,280 -32,960	-47%	-$1.81M	0.02%	846
2016 Q2	$3.81M	Sell	70,240 -96,000	-58%	-$5.06M	0.05%	500
2016 Q1	$8.43M	Buy	166,240 +36,720	+28%	+$1.83M	0.12%	174
2015 Q4	$6.53M	Buy	129,520 +66,480	+105%	+$3.39M	0.08%	270
2015 Q3	$3.03M	Buy	63,040 +17,440	+38%	+$908K	0.04%	567
2015 Q2	$2.37M	Buy	45,600 +7,120	+19%	+$401K	0.03%	647
2015 Q1	$2.22M	Buy	38,480 +26,880	+232%	+$1.54M	0.03%	584
2014 Q4	$620K	Buy	11,600 +4,800	+71%	+$269K	0.01%	1390
2014 Q3	$391K	Buy	+6,800	New	+$417K	0.01%	1800

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading's GSK Position: Q3 2025 in Review

Group One Trading sold out of GSK (GSK) in Q3 2025, closing a stake of 38,563 shares — an estimated $1.51M sold.

Group One Trading first reported a position in GSK in Q2 2014 and held it in 24 quarters. The position peaked at $10.1M in Q2 2021. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Group One Trading reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 38,563 GSK shares in Q3 2025, an estimated $1.51M.
Group One Trading first reported a position in GSK in Q2 2014 and held it in 24 quarters.
Group One Trading's GSK position peaked at $10.1M in Q2 2021.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.